Reuters logo
BRIEF-A1M: ROSGard shows renal protective effect during radiation therapy
December 9, 2016 / 1:59 PM / a year ago

BRIEF-A1M: ROSGard shows renal protective effect during radiation therapy

Dec 9 (Reuters) - A1M Pharma AB :

* Announces that the active substance in the company’s candidate drug ROSGard shows a strong renal protective effect in connection with radiation therapy (PRRT) in a short-term preclinical study with an animal model

* Results of the effect 6 months after treatment are expected by the end of Q1 2017 Source text: bit.ly/2hbcBhL

Further company coverage:

Gdynia Newsroom

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below